Pediatrix Medical Group, Inc. (NYSE:MD) Stake Lessened by WINTON GROUP Ltd

WINTON GROUP Ltd trimmed its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 17.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 89,981 shares of the company’s stock after selling 18,705 shares during the quarter. WINTON GROUP Ltd owned approximately 0.10% of Pediatrix Medical Group worth $1,181,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Quest Partners LLC grew its position in shares of Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares in the last quarter. Everence Capital Management Inc. increased its stake in Pediatrix Medical Group by 7.5% during the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after purchasing an additional 960 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after buying an additional 1,040 shares during the last quarter. Quarry LP boosted its holdings in shares of Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after buying an additional 1,662 shares during the period. Finally, AlphaQuest LLC boosted its holdings in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have issued reports on MD. UBS Group raised their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Macquarie started coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Truist Financial increased their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday, February 21st. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 5.8 %

NYSE:MD opened at $14.15 on Friday. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -11.79, a PEG ratio of 1.74 and a beta of 1.49. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The business has a fifty day moving average of $14.40 and a 200-day moving average of $13.65.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.